Vicarious Surgical Beheer
Beheer criteriumcontroles 3/4
Vicarious Surgical's CEO is Adam Sachs, appointed in Jan 2014, has a tenure of 10.83 years. total yearly compensation is $3.13M, comprised of 17.1% salary and 82.9% bonuses, including company stock and options. directly owns 6.73% of the company’s shares, worth $3.20M. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.
Belangrijke informatie
Adam Sachs
Algemeen directeur
US$3.1m
Totale compensatie
Percentage CEO-salaris | 17.1% |
Dienstverband CEO | 10.8yrs |
Eigendom CEO | 6.7% |
Management gemiddelde ambtstermijn | 3.2yrs |
Gemiddelde ambtstermijn bestuur | 3.2yrs |
Recente managementupdates
Recent updates
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02
Aug 08Vectoring In On Vicarious Surgical Inc.
Jun 23Vicarious Surgical: Developing Minimally Invasive VR Surgical System
Nov 29Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$61m |
Mar 31 2024 | n/a | n/a | -US$61m |
Dec 31 2023 | US$3m | US$537k | -US$71m |
Sep 30 2023 | n/a | n/a | -US$69m |
Jun 30 2023 | n/a | n/a | -US$78m |
Mar 31 2023 | n/a | n/a | -US$64m |
Dec 31 2022 | US$5m | US$531k | US$5m |
Sep 30 2022 | n/a | n/a | US$38m |
Jun 30 2022 | n/a | n/a | US$18m |
Mar 31 2022 | n/a | n/a | US$13m |
Dec 31 2021 | US$6m | US$268k | -US$35m |
Sep 30 2021 | n/a | n/a | -US$61m |
Jun 30 2021 | n/a | n/a | -US$19m |
Mar 31 2021 | n/a | n/a | -US$15m |
Dec 31 2020 | US$187k | US$180k | -US$13m |
Compensatie versus markt: Adam's total compensation ($USD3.13M) is above average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Adam's compensation has been consistent with company performance over the past year.
CEO
Adam Sachs (32 yo)
10.8yrs
Tenure
US$3,134,667
Compensatie
Mr. Adam David Sachs is Co-Founder at Vicarious Surgical Inc. in 2014. He serves as Chief Executive Officer and Director of Vicarious Surgical Inc. (Formerly, D8 Holdings Corp.) since September 2021. He se...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 10.8yrs | US$3.13m | 6.73% $ 3.2m | |
Co-founder | 3.2yrs | US$1.82m | 2.83% $ 1.3m | |
CFO & Treasurer | 3.2yrs | US$1.64m | 0.013% $ 6.0k | |
President | less than a year | geen gegevens | geen gegevens | |
Co-founder & Chief Medical Officer | no data | geen gegevens | 2.2% $ 1.0m | |
Chief Operating Officer | 2.8yrs | geen gegevens | 0.045% $ 21.6k | |
Head of Legal & Secretary | no data | geen gegevens | geen gegevens | |
Vice President of Business Operations & People | 3.2yrs | geen gegevens | geen gegevens |
3.2yrs
Gemiddelde duur
49yo
Gemiddelde leeftijd
Ervaren management: RBOT's management team is considered experienced (3.2 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 3.2yrs | US$3.13m | 6.73% $ 3.2m | |
Co-founder | 3.2yrs | US$1.82m | 2.83% $ 1.3m | |
Independent Director | 2.1yrs | US$196.56k | 0.078% $ 37.1k | |
Independent Director | 3.2yrs | US$195.77k | 0.063% $ 30.2k | |
Independent Director | 3.2yrs | US$198.45k | 0.15% $ 72.4k | |
Independent Director | 1.8yrs | US$447.60k | 0.054% $ 25.7k | |
Independent Director | 3.2yrs | US$185.14k | 0.71% $ 338.1k |
3.2yrs
Gemiddelde duur
49yo
Gemiddelde leeftijd
Ervaren bestuur: RBOT's board of directors are considered experienced (3.2 years average tenure).